Literature DB >> 35513755

Dental management in head and neck cancers: from intensity-modulated radiotherapy with photons to proton therapy.

Sabah Falek1, Rajesh Regmi2, Joel Herault3, Melanie Dore4, Anthony Vela5, Pauline Dutheil5, Cyril Moignier5, Pierre-Yves Marcy6, Julien Drouet1, Arnaud Beddok7, Noah E Letwin8, Joel Epstein9, Upendra Parvathaneni10, Juliette Thariat11,12,13,14.   

Abstract

INTRODUCTION: Despite reduction of xerostomia with intensity-modulated compared to conformal X-ray radiotherapy, radiation-induced dental complications continue to occur. Proton therapy is promising in head and neck cancers to further reduce radiation-induced side-effects, but the optimal dental management has not been defined.
MATERIAL AND METHODS: Dental management before proton therapy was assessed compared to intensity-modulated radiotherapy based on a bicentric experience, a literature review and illustrative cases.
RESULTS: Preserved teeth frequently contain metallic dental restorations (amalgams, crowns, implants). Metals blur CT images, introducing errors in tumour and organ contour during radiotherapy planning. Due to their physical interactions with matter, protons are more sensitive than photons to tissue composition. The composition of restorative materials is rarely documented during radiotherapy planning, introducing dose errors. Manual artefact recontouring, metal artefact-reduction CT algorithms, dual or multi-energy CT and appropriate dose calculation algorithms insufficiently compensate for contour and dose errors during proton therapy. Physical uncertainties may be associated with lower tumour control probability and more side-effects after proton therapy. Metal-induced errors should be quantified and removal of metal restorations discussed on a case by case basis between dental care specialists, radiation oncologists and physicists. Metallic amalgams can be replaced with water-equivalent materials and crowns temporarily removed depending on rehabilitation potential, dental condition and cost. Implants might contraindicate proton therapy if they are in the proton beam path.
CONCLUSION: Metallic restorations may more severely affect proton than photon radiotherapy quality. Personalized dental care prior to proton therapy requires multidisciplinary assessment of metal-induced errors before choice of conservation/removal of dental metals and optimal radiotherapy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Artefacts; CT; Cancer; Dental / teeth; Head and neck; Proton therapy; Radiotherapy

Mesh:

Substances:

Year:  2022        PMID: 35513755     DOI: 10.1007/s00520-022-07076-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  69 in total

1.  Does intensity-modulated radiation therapy lower the risk of osteoradionecrosis of the jaw? A long-term comparative analysis.

Authors:  R Willaert; D Nevens; A Laenen; M Batstone; C Politis; S Nuyts
Journal:  Int J Oral Maxillofac Surg       Date:  2019-06-20       Impact factor: 2.789

Review 2.  Proton therapy for head and neck cancer: expanding the therapeutic window.

Authors:  Jonathan E Leeman; Paul B Romesser; Ying Zhou; Sean McBride; Nadeem Riaz; Eric Sherman; Marc A Cohen; Oren Cahlon; Nancy Lee
Journal:  Lancet Oncol       Date:  2017-04-26       Impact factor: 41.316

Review 3.  Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.

Authors:  Joel B Epstein; Juliette Thariat; Rene-Jean Bensadoun; Andrei Barasch; Barbara A Murphy; Leanne Kolnick; Leslie Popplewell; Ellie Maghami
Journal:  CA Cancer J Clin       Date:  2012-09-12       Impact factor: 508.702

Review 4.  Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis.

Authors:  Samir H Patel; Zhen Wang; William W Wong; Mohammad Hassan Murad; Courtney R Buckey; Khaled Mohammed; Fares Alahdab; Osama Altayar; Mohammed Nabhan; Steven E Schild; Robert L Foote
Journal:  Lancet Oncol       Date:  2014-06-26       Impact factor: 41.316

5.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Authors:  Christopher M Nutting; James P Morden; Kevin J Harrington; Teresa Guerrero Urbano; Shreerang A Bhide; Catharine Clark; Elizabeth A Miles; Aisha B Miah; Kate Newbold; MaryAnne Tanay; Fawzi Adab; Sarah J Jefferies; Christopher Scrase; Beng K Yap; Roger P A'Hern; Mark A Sydenham; Marie Emson; Emma Hall
Journal:  Lancet Oncol       Date:  2011-01-12       Impact factor: 41.316

6.  Functional evaluation of mandibular reconstruction with bone free flap. A GETTEC study.

Authors:  S Atallah; A Bozec; P Ransy; J Davrou; J Longis; M Humbert; E Brenet; P Schultz; A Damecourt; J Lacau Saint Guily; B Baujat
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2020-08-14       Impact factor: 2.080

Review 7.  Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer.

Authors:  Tineke W H Meijer; Dan Scandurra; Johannes A Langendijk
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

8.  Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.

Authors:  Chiaojung Jillian Tsai; Theresa M Hofstede; Erich M Sturgis; Adam S Garden; Mary E Lindberg; Qingyi Wei; Susan L Tucker; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-12       Impact factor: 7.038

9.  Pre-radiotherapy dental extractions in patients with head and neck cancer: a Delphi study.

Authors:  Ciaran Moore; Conor McLister; Ciaran O'Neill; Michael Donnelly; Gerald McKenna
Journal:  J Dent       Date:  2020-05-01       Impact factor: 4.379

10.  Dental caries following radiotherapy for head and neck cancer: A systematic review.

Authors:  Ciaran Moore; Conor McLister; Christopher Cardwell; Ciaran O'Neill; Michael Donnelly; Gerald McKenna
Journal:  Oral Oncol       Date:  2019-11-28       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.